Plus, news about Imaavy.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Confirm Endpoints as a trusted biopharma news source
Bioscience & Technology Business Center
The University of Kansas
Sensorion axes hearing loss program; Novartis' biomarker data in muscular dystrophy
Sensorion selects one hearing loss program, axes another; Novartis hits biomarker endpoint for muscular dystrophy drug; J&J's antibody succeeds in blood disorder
45 words~1 min read
